1. Bedside ultrasound to evaluate abdominal pain. Issue 11 (November 2015) Authors: Scott, Clare Journal: JAAPA Issue: Volume 28:Issue 11(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Decoding transcriptomic intra‐tumour heterogeneity to guide personalised medicine in ovarian cancer. Issue 3 (18th December 2018) Authors: Tan, Tuan Zea; Heong, Valerie; Ye, Jieru; Lim, Diana; Low, Jeffrey; Choolani, Mahesh; Scott, Clare; Tan, David Shao Peng; Huang, Ruby Yun‐Ju Journal: Journal of pathology Issue: Volume 247:Issue 3(2019) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial. Issue 8 (August 2018) Authors: Friedlander, Michael; Gebski, Val; Gibbs, Emma; Davies, Lucy; Bloomfield, Ralph; Hilpert, Felix; Wenzel, Lari B; Eek, Daniel; Rodrigues, Manuel; Clamp, Andrew; Penson, Richard T; Provencher, Diane; Korach, Jacob; Huzarski, Tomasz; Vidal, Laura; Salutari, Vanda; Scott, Clare; Nicoletto, Maria Orne... Journal: Lancet oncology Issue: Volume 19:Issue 8(2018) Page Start: 1126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Influence of muscle metaboreceptor stimulation on middle cerebral artery blood velocity in humans. Issue 11 (18th October 2014) Authors: Braz, Igor D.; Scott, Clare; Simpson, Lydia L.; Springham, Emma L.; Tan, Beverly W. L.; Balanos, George M.; Fisher, James P. Journal: Experimental physiology Issue: Volume 99:Issue 11(2014:Nov.) Page Start: 1478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. Issue 9 (30th October 2018) Authors: Friedlander, Michael; Matulonis, Ursula; Gourley, Charlie; du Bois, Andreas; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira-Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Shirinkin, Vadim; Selle, Frédéric; Fielding, Anitra; Lowe, Elizabeth; McMurtry, Emma; Spencer, Stuart; ... Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1075 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Olaparib maintenance therapy in patients with platinum‐sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. Issue 12 (8th April 2016) Authors: Matulonis, Ursula A.; Harter, Philipp; Gourley, Charlie; Friedlander, Michael; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira‐Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Fielding, Anitra; Spencer, Stuart; Parry, David; Grinsted, Lynda; Ledermann, Jonathan A. Journal: Cancer Issue: Volume 122:Issue 12(2016) Page Start: 1844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021) Authors: Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A; Asher, Rebecca; Penson, Richard T; Oza, Amit M; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Elias A... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. Issue 11 (November 2016) Authors: Ledermann, Jonathan A; Harter, Philipp; Gourley, Charlie; Friedlander, Michael; Vergote, Ignace; Rustin, Gordon; Scott, Clare; Meier, Werner; Shapira-Frommer, Ronnie; Safra, Tamar; Matei, Daniela; Fielding, Anitra; Spencer, Stuart; Rowe, Philip; Lowe, Elizabeth; Hodgson, Darren; Sovak, Mika A; Ma... Journal: Lancet oncology Issue: Volume 17:Issue 11(2016:Nov.) Page Start: 1579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib. Issue 6 (26th November 2018) Authors: Friedlander, Michael; Shannon, Catherine; Goh, Jeffrey; Scott, Clare; Mileshkin, Linda Journal: Asia-Pacific journal of clinical oncology Issue: Volume 14:Issue 6(2018) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum‐sensitive recurrent ovarian cancer. Issue 4 (December 2016) Authors: Friedlander, Michael; Banerjee, Susana; Mileshkin, Linda; Scott, Clare; Shannon, Catherine; Goh, Jeffrey Journal: Asia-Pacific journal of clinical oncology Issue: Volume 12:Issue 4(2016) Page Start: 323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗